Table 1.
Tumour subtypes for cancer patients (with or without metastasis) hospitalized in France for COVID-19 (from 1 March 2020, to 30 April 2020).
| All Cancer n = 5722 |
Solid Metastatic Cancer n = 1775 |
Solid Cancer without Metastasis n = 2558 |
||||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| Hematological | 1.89 | 24.3 | - | - | - | - |
| Lung | 873 | 15.3 | 461 | 26.0 | 412 | 16.1 |
| Digestive (non-colorectal) | 626 | 10.9 | 244 | 13.8 | 382 | 14.9 |
| Prostate | 621 | 10.9 | 196 | 11.0 | 425 | 16.6 |
| Breast | 561 | 9.8 | 241 | 13.6 | 320 | 12.5 |
| Colorectal | 518 | 9.1 | 244 | 13.8 | 274 | 10.7 |
| Urinary tract | 363 | 6.3 | 128 | 7.2 | 235 | 9.2 |
| Other cancers * | 303 | 5.3 | 54 | 3.0 | 249 | 9.7 |
| Female genital organs | 185 | 3.2 | 119 | 6.7 | 66 | 2.6 |
| Lip, oral cavity and pharynx | 162 | 2.8 | 45 | 2.5 | 117 | 4.6 |
| Skin | 121 | 2.1 | 43 | 2.4 | 78 | 3.1 |
* including mesothelial and soft issue, respiratory and intrathoracic organs (except lung), bone and articular cartilage, endocrine glands, other cancers in males and central nervous system.